Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Rein Therapeutics Inc. (RNTX) had Normalized Pre-Tax Income of $-6.38M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-6.38M |
|
-- |
|
-- |
|
$6.08M |
|
$-6.08M |
|
$-0.30M |
|
$-6.38M |
|
|
Normalized Pre-Tax Income |
$-6.38M |
$-6.38M |
|
$-6.38M |
|
$-6.38M |
|
$-6.38M |
|
$-6.08M |
|
$-5.62M |
|
67.08M |
|
67.08M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$41.45M |
|
-- |
|
$24.52M |
|
$65.97M |
|
$9.71M |
|
-- |
|
$46.06M |
|
$55.77M |
|
$10.20M |
|
$-9.63M |
|
$10.20M |
|
85.77M |
|
| Cash Flow Statement Financials | |
$-12.06M |
|
$-35.07M |
|
$52.47M |
|
$3.21M |
|
$8.54M |
|
$5.33M |
|
$0.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-62.51% |
|
66.19% |
|
-9.66% |
|
-62.51% |
|
$0.12 |
|
$-0.18 |
|
$-0.18 |
|